Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19004807 | 0.80 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR | |
| SCHEMBL10043017 | 0.80 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR | |
| SCHEMBL2549272 | 0.80 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR | |
| SCHEMBL22553629 | 0.73 | DPP4 (0.37) | — | |
| SCHEMBL31512694 | 0.69 | LMNA (0.47) | — | |
| SCHEMBL218726 | 0.69 | ALDH1A1 (0.54) | ALDH1A1ALOX15TSHRCYP1A2 | |
| SCHEMBL12036750 | 0.67 | LMNA (0.50) | ALDH1A1CYP1A2 | |
| SCHEMBL12036809 | 0.67 | PDE4A (0.40) | CYP1A2 | |
| SCHEMBL29344559 | 0.67 | ALDH1A1 (0.41) | ALDH1A1ALOX15TSHR | |
| SCHEMBL1323446 | 0.67 | ALDH1A1 (0.50) | ALDH1A1ALOX15TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119968373-A | Aromatic heterocyclic compound and preparation method thereof | 上海翊石医药科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025051214-A1 | AROMATIC HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR | 上海翊石医药科技有限公司 | 2025-03-13 | — | — | WO | disclosed |
| WO-2019149260-A1 | PYRIDAZINOL COMPOUND, DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | 青岛清原化合物有限公司 | 2019-08-08 | — | — | WO | disclosed |
| US-9732100-B2 | Preparation of alkaline earth metal-complexed metal bisamides from metal monoamides | BAYER CROPSCIENCE AG (DE) | 2017-08-15 | — | — | US | disclosed |
| EP-2956460-B1 | PREPARATION OF ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES FROM METAL MONOAMIDES | BAYER CROPSCIENCE AG (DE) | 2017-03-22 | — | — | EP | disclosed |
| CN-104220423-B | The metal bisamide of alkaline-earth metal complexing | 拜耳知识产权有限责任公司 | 2016-06-15 | — | — | CN | disclosed |
| US-9334292-B2 | Alkaline earth metal-complexed metal bisamides | BAYER CROPSCIENCE AG (DE) | 2016-05-10 | — | — | US | disclosed |
| US-20160016977-A1 | ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-01-21 | — | — | US | disclosed |
| US-20150368277-A1 | PREPARATION OF ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES FROM METAL MONOAMIDES | BAYER CROPSCIENCE AG (DE) | 2015-12-24 | — | — | US | disclosed |
| EP-2956460-A1 | PREPARATION OF ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES FROM METAL MONOAMIDES | Bayer CropScience Aktiengesellschaft (DE) | 2015-12-23 | — | — | EP | disclosed |
| EP-2814811-B1 | ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES | BAYER IP GMBH (DE) | 2015-12-02 | — | — | EP | disclosed |
| EP-2814811-A1 | ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES | Bayer Intellectual Property GmbH (DE) | 2014-12-24 | — | — | EP | disclosed |
| WO-2014124915-A1 | PREPARATION OF ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES FROM METAL MONOAMIDES | BAYER CROPSCIENCE AG (DE) | 2014-08-21 | — | — | WO | disclosed |
| WO-2013120911-A1 | ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-08-22 | — | — | WO | disclosed |
| WO-2013078254-A1 | BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2013-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368277-A1 | PREPARATION OF ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES FROM METAL MONOAMIDES | ASH2L, NAAA, MGAM2 | ALDH1A1 1597/4885ALOX15 1875/4885TSHR 4076/4885 |
| US-20160016977-A1 | ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES | AP1M1, FHIT, AP2M1 | ALDH1A1 1035/4885ALOX15 2926/4885TSHR 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.